H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research Report ... The company has shown consistent execution in its clinical programs, ...

Oklo Inc. ("Oklo"), an advanced fission power and nuclear fuel recycling company, has received Letters of Intent (LOIs) and is partnering with two major data center providers to deliver up to 750 ...

With innovative clinical research services and custom-tailored solutions, Ergomed ensures that oncology treatments progress ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

The Children’s Inn at NIH, a private nonprofit that supports kids in clinical trials, just broke ground on a long-planned ...

Research Program: Nitric Oxide Formulation, AROMUC 5AC, Lonodelestat, AZD-0292, CSL 787, Inhaled Murepavadin, NM001, SPL 5AC, Mucolytic Agents, and others are under different phases of non-cystic ...

They used advanced health monitoring technology to gain insights into the rats’ sleep patterns, including the amount of sleep ...

Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...

He highlighted that companies should plan for the long term, even during the early phases of development ... overlooked ...